ResearcherUniversity of HelsinkiActive in the last 2 years
James R. W. Conway
Matched on ORCID iD 0000-0003-3787-277X; OpenAlex author ID A5035661681. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Pancreatic cancer cells breach endothelial barriers through protrusion-driven invasion or endothelial retraction Co-author DOI 10.64898/2026.09.02.749041↗
- Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status. Co-author DOI 10.1126/sciadv.abh0363↗
- Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. Co-author DOI 10.1136/gutjnl-2018-316822↗
- Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2018.05.038↗
- SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. Co-author DOI 10.1038/onc.2017.63↗
- Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Co-author DOI 10.1126/scitranslmed.aai8504↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David Herrmann · 4 shared papers, 2017–2021 · strength 0.32
- Paper Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. DOI 10.1136/gutjnl-2018-316822↗
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Jennifer P. Morton · 4 shared papers, 2017–2021 · strength 0.32
- Paper Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. DOI 10.1136/gutjnl-2018-316822↗
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Paul Timpson · 4 shared papers, 2017–2021 · strength 0.32
- Paper Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. DOI 10.1136/gutjnl-2018-316822↗
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Guillaume Jacquemet · 1 shared paper, 2026 · strength 0.24
- Gautier Follain · 1 shared paper, 2026 · strength 0.24
- Claire Vennin · 3 shared papers, 2017–2021 · strength 0.19
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Paper SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. DOI 10.1038/onc.2017.63↗
- Marina Pajic · 3 shared papers, 2017–2021 · strength 0.19
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Paper SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. DOI 10.1038/onc.2017.63↗
- Yingxiao Wang · 2 shared papers, 2018–2021 · strength 0.14
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Max Nobis · 2 shared papers, 2018–2021 · strength 0.14
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Kendelle Joan Murphy · 2 shared papers, 2018–2021 · strength 0.14
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Owen James Sansom · 2 shared papers, 2018–2021 · strength 0.14
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pan… DOI 10.1016/j.celrep.2018.05.038↗
- Andrew Victor Biankin · 2 shared papers, 2017–2021 · strength 0.13
- Ashleigh Parkin · 1 shared paper, 2021 · strength 0.08
- Michael Tayao · 1 shared paper, 2021 · strength 0.08
- Jaswinder Singh Samra · 1 shared paper, 2021 · strength 0.08
- Angela S. Y. Chou · 1 shared paper, 2021 · strength 0.08
- Shona Ritchie · 1 shared paper, 2021 · strength 0.08
- Thomas R. Cox · 1 shared paper, 2021 · strength 0.08
- Amber L. Johns · 1 shared paper, 2021 · strength 0.08
- Cecilia R. Chambers · 1 shared paper, 2021 · strength 0.08
- Roger J. Daly · 1 shared paper, 2021 · strength 0.08
- Sean Michael Grimmond · 1 shared paper, 2021 · strength 0.08
- Anthony James Gill · 1 shared paper, 2021 · strength 0.08
- Brooke Pereira · 1 shared paper, 2021 · strength 0.08
- Australian Pancreatic Cancer Genome Initiative (APGI) · 1 shared paper, 2021 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.